One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A

Autophagy Mediates Tolerance to Staphylococcus aureus Alpha-Toxin

(2015) Katie Maurer et al.   Cell Host & Microbe

The 3 major types of innate and adaptive cell-mediated effector immunity

(2015) Francesco Annunziato et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

TH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26

(2015) Stephan Meller et al.   NATURE IMMUNOLOGY

Efficacy profile of a bivalent Staphylococcus aureusglycoconjugated vaccine in adults on hemodialysis: Phase III randomized study

(2015) Ali Fattom et al.   Human Vaccines & Immunotherapeutics

Recombinant ESAT-6-Like Proteins Provoke Protective Immune Responses against Invasive Staphylococcus aureus Disease in a Murine Model

(2014) Bao Zhong Zhang et al.   INFECTION AND IMMUNITY

Staphylococcal Esx Proteins Modulate Apoptosis and Release of Intracellular Staphylococcus aureus during Infection in Epithelial Cells

(2014) Charalampia G. Korea et al.   INFECTION AND IMMUNITY

Staphylococcus aureus Infection of Mice Expands a Population of Memory    T Cells That Are Protective against Subsequent Infection

(2014) A. G. Murphy et al.   JOURNAL OF IMMUNOLOGY

Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants

(2014) C. Maisonneuve et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Rational design of small molecules as vaccine adjuvants

(2014) T. Y.- H. Wu et al.   Science Translational Medicine

Neutrophil-Mediated Phagocytosis of Staphylococcus aureus

(2014) Kok P. M. van Kessel et al.   Frontiers in Immunology

Mining the bacterial unknown proteome: identification and characterization of a novel family of highly conserved protective antigens inStaphylococcus aureus

(2013) Christina Schluepen et al.   BIOCHEMICAL JOURNAL

The use of Toll-like receptor 7/8 agonists as vaccine adjuvants

(2013) John P Vasilakos et al.   Expert Review of Vaccines

Nlrp-3-Driven Interleukin 17 Production by γδT Cells Controls Infection Outcomes during Staphylococcus aureus Surgical Site Infection

(2013) Belinda M. Maher et al.   INFECTION AND IMMUNITY

Key roles of adjuvants in modern vaccines

(2013) Steven G Reed et al.   NATURE MEDICINE

Staphylococcus aureus α-Toxin: Nearly a Century of Intrigue

(2013) Bryan Berube et al.   Toxins

Epidemiology and outcome of major postoperative infections following cardiac surgery: Risk factors and impact of pathogen type

(2012) Luke F. Chen et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Structural and functional characterization of theStaphylococcus aureusvirulence factor and vaccine candidate FhuD2

(2012) Paolo Mariotti et al.   BIOCHEMICAL JOURNAL

Challenges for a Universal Staphylococcus aureus Vaccine

(2012) R. A. Proctor   CLINICAL INFECTIOUS DISEASES

Predictors of Mortality in Staphylococcus aureus Bacteremia

(2012) S. J. van Hal et al.   CLINICAL MICROBIOLOGY REVIEWS

Immunity to infection in IL-17-deficient mice and humans

(2012) Sophie Cypowyj et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Abscess Formation and Alpha-Hemolysin Induced Toxicity in a Mouse Model of Staphylococcus aureus Peritoneal Infection

(2012) Sabine Rauch et al.   INFECTION AND IMMUNITY

Staphylococcus aureus FhuD2 Is Involved in the Early Phase of Staphylococcal Dissemination and Generates Protective Immunity in Mice

(2012) Ravi P. N. Mishra et al.   JOURNAL OF INFECTIOUS DISEASES

Immunization withStaphylococcus aureusiron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model

(2012) Amita Joshi et al.   Human Vaccines & Immunotherapeutics

Role of Interleukin-17A in Cell-Mediated Protection against Staphylococcus aureus Infection in Mice Immunized with the Fibrinogen-Binding Domain of Clumping Factor A

(2010) K. Narita et al.   INFECTION AND IMMUNITY

IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice

(2010) John S. Cho et al.   JOURNAL OF CLINICAL INVESTIGATION

Targeting of Alpha‐Hemolysin by Active or Passive Immunization Decreases Severity of USA300 Skin Infection in a Mouse Model

(2010) Adam D. Kennedy et al.   JOURNAL OF INFECTIOUS DISEASES

IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge

(2010) Hwan Keun Kim et al.   VACCINE

Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues

(2009) Alice G. Cheng et al.   FASEB JOURNAL

Differential Roles of Interleukin-17A and -17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses

(2009) Harumichi Ishigame et al.   IMMUNITY

Incidence of and Preoperative Risk Factors for Staphylococcus aureus Bacteremia and Chest Wound Infection After Cardiac Surgery

(2009) Zeina A. Kanafani et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

International Study of the Prevalence and Outcomes of Infection in Intensive Care Units

(2009) Jean-Louis Vincent   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice

(2009) Lin Lin et al.   PLoS Pathogens

Immunological Mechanisms Underlying the Genetic Predisposition to Severe Staphylococcus aureus Infection in the Mouse Model

(2008) Maren von Köckritz-Blickwede et al.   AMERICAN JOURNAL OF PATHOLOGY

Vaccine protection againstStaphylococcus aureuspneumonia

(2008) Juliane Bubeck Wardenburg et al.   JOURNAL OF EXPERIMENTAL MEDICINE